Variability of Delivery of Timolol for the Treatment of Infantile Hemangiomas

ConclusionStatistically significant differences were noted in the amount of timolol dispensed according to formulation, brand, and user. Whether this is clinically significant is unknown given the lack of pharmacokinetic data available for timolol.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fpde.13189

Source: Pediatric Dermatology - June 29, 2017 Category: Dermatology Authors: JiaDe Yu, Tucker Keuter, Kala Schilter, Marcia Seefeldt, Brittney Bates, Katherine Mueller, Beth A. Drolet Tags: Original Article Source Type: research